Dis-Chem Pharmacies (JSE:DCP) EBIT : R1,851 Mil (TTM As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies EBIT?

Dis-Chem Pharmacies's earnings before interest and taxes (EBIT) for the six months ended in Feb. 2024 was R936 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2024 was R1,851 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Dis-Chem Pharmacies's annualized ROC % for the quarter that ended in Feb. 2024 was 16.19%. Dis-Chem Pharmacies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was 29.09%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2024 was 5.71%.

Dis-Chem Pharmacies EBIT Historical Data

The historical data trend for Dis-Chem Pharmacies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies EBIT Chart

Dis-Chem Pharmacies Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

EBIT

Get a 7-Day Free Trial

1,270.89

1,285.52

1,552.71

1,787.17

1,850.81

Dis-Chem Pharmacies Semi-Annual Data
	Feb14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
EBIT	Get a 7-Day Free Trial															788.09	1,016.97	770.21	914.78	936.04

Competitive Comparison of Dis-Chem Pharmacies's EBIT

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dis-Chem Pharmacies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's EV-to-EBIT falls into.

Dis-Chem Pharmacies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was R1,851 Mil.

Dis-Chem Pharmacies (JSE:DCP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Dis-Chem Pharmacies's annualized ROC % for the quarter that ended in Feb. 2024 is calculated as:

	ROC % (Q: Feb. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Aug. 2023 )	+	Invested Capital (Q: Feb. 2024 ))	/ count )
=	2042.03 * ( 1 - 26.49% )	/	( (8836.704	+	9703.986)	/ 2 )
=	1501.096253	/	9270.345
=	16.19 %

where

	Invested Capital		(Q: Aug. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	16574.734	-	6949.14	-	( 788.89	-	max(0, 8951.406	-	10545.26	+	788.89	))
=	8836.704

	Invested Capital		(Q: Feb. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	17500.986	-	6912.629	-	( 884.371	-	max(0, 9183.078	-	10922.955	+	884.371	))
=	9703.986

Note: The Operating Income data used here is two times the semi-annual (Feb. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Dis-Chem Pharmacies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Feb. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Aug. 2023		Q: Feb. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	1872.07	/	( ( (4267.477 + max(2288.255, 0))	+	(4799.705 + max(1515.272, 0)) )	/	2 )
=	1872.07	/	( ( 6555.732	+	6314.977 )	/	2 )
=	1872.07	/	6435.3545
=	29.09 %

where Working Capital is:

	Working Capital		(Q: Aug. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2688.698	+	6927.032	+	0)	-	(6949.14	+	0	+	378.335)
=	2288.255

	Working Capital		(Q: Feb. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1374.422	+	7162.558	+	240.059)	-	(6912.629	+	0	+	349.138)
=	1515.272

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Feb. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Feb. 2024 )
	=	1850.814	/	32386.509
	=	5.71 %

Dis-Chem Pharmacies EBIT Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Dis-Chem Pharmacies (JSE:DCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685

Website

https://www.dischem.co.za

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.